Premedication with simethicone and N-acetylcysteine for improving mucosal visibility during upper gastrointestinal endoscopy in a Western population
- PMID: 33532557
- PMCID: PMC7834924
- DOI: 10.1055/a-1315-0114
Premedication with simethicone and N-acetylcysteine for improving mucosal visibility during upper gastrointestinal endoscopy in a Western population
Abstract
Background and study aim Pre-endoscopic use of a preparation with tensioactive and mucolytic agents improved gastric mucosa visualization in Eastern studies. Data on Western population are scanty. Patients and methods This prospective, endoscopist-blinded, randomized study enrolled patients who underwent esophagogastroduodenoscopy in a single center. Before endoscopy patients, were randomized to receive or not receive an oral preparation with simethicone and N-acetylcysteine in water. A pretested score (Crema Stomach Cleaning Score [CSCS]) for gastric mucosa cleaning evaluation was used. In detail, the stomach was divided into the antrum, body, and fundus and a score of 1 to 3 was assigned to each part (the higher the score, the better the preparation), and a total value ≤ 5 was considered as insufficient. Time between endoscope insertion and clean achievement (mouth to clean time) or the end of examination (mouth to mouth time) was recorded. Results A total of 197 patients were enrolled. The mean overall CSCS value and mucosal cleaning in all parts was better in treated patients than in controls. Prevalence total score ≤ 5 was significantly lower in patients treated before endoscopy. Need for water flush occurred less frequently in treated patients ( P < 0.0001). The mouth to clean time was lower in the treated than in the control group (2.3 ± 1.6 vs 3.8 ± 1.6 min; P < 0.001), whereas no significant difference in mouth to mouth time emerged. Conclusions Data from this study show that premedication with simethicone and N-acetylcysteine results in significantly better endoscopic visualization of gastric mucosa, and the proposed CSCS could be useful for standardizing this evaluation.
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Conflict of interest statement
Competing interests The authors declare that they have no conflict of interest.
Similar articles
-
Efficacy of simethicone and N-acetylcysteine as premedication in improving visibility during upper endoscopy.J Gastroenterol Hepatol. 2014 Apr;29(4):769-74. doi: 10.1111/jgh.12487. J Gastroenterol Hepatol. 2014. PMID: 24325147 Clinical Trial.
-
The Effect of Using Premedication of Simethicone/Pronase With or Without Postural Change on Visualization of the Mucosa Before Endoscopy: A Prospective, Double Blinded, Randomized Controlled Trial.Clin Transl Gastroenterol. 2024 Feb 1;15(2):e00625. doi: 10.14309/ctg.0000000000000625. Clin Transl Gastroenterol. 2024. PMID: 37581331 Free PMC article. Clinical Trial.
-
Premedication with N-acetylcysteine and simethicone improves mucosal visualization during gastroscopy: a randomized, controlled, endoscopist-blinded study.Eur J Gastroenterol Hepatol. 2013 Jul;25(7):778-83. doi: 10.1097/MEG.0b013e32836076b2. Eur J Gastroenterol Hepatol. 2013. PMID: 23739279 Clinical Trial.
-
Premedication in upper gastrointestinal endoscopy to improve mucosal visualization. A systematic review.Rev Gastroenterol Peru. 2024 Oct-Dec;44(4):346-353. Rev Gastroenterol Peru. 2024. PMID: 39825811 English.
-
The effect of using simethicone with or without N-acetylcysteine before gastroscopy: A meta-analysis and systemic review.Saudi J Gastroenterol. 2019 Jul-Aug;25(4):218-228. doi: 10.4103/sjg.SJG_538_18. Saudi J Gastroenterol. 2019. PMID: 31044749 Free PMC article.
Cited by
-
Premedication with simethicone for improving the quality of gastric mucosal visualization: a double-blind randomized controlled trial.Endosc Int Open. 2022 Oct 17;10(10):E1343-E1349. doi: 10.1055/a-1922-7773. eCollection 2022 Oct. Endosc Int Open. 2022. PMID: 36262507 Free PMC article.
-
Computer-Based Diagnosis of Celiac Disease by Quantitative Processing of Duodenal Endoscopy Images.Diagnostics (Basel). 2023 Aug 28;13(17):2780. doi: 10.3390/diagnostics13172780. Diagnostics (Basel). 2023. PMID: 37685318 Free PMC article.
-
Optimal timing of simethicone administration prior to upper endoscopy: A multicenter, single-blind, randomized controlled trial.Endosc Int Open. 2023 Oct 17;11(10):E992-E1000. doi: 10.1055/a-2157-5034. eCollection 2023 Oct. Endosc Int Open. 2023. PMID: 37854124 Free PMC article.
-
N-Acetylcysteine (NAC): Impacts on Human Health.Antioxidants (Basel). 2021 Jun 16;10(6):967. doi: 10.3390/antiox10060967. Antioxidants (Basel). 2021. PMID: 34208683 Free PMC article. Review.
-
Pre-medication with simethicone and N-acetyl cysteine for improving mucosal visibility during upper gastrointestinal endoscopy: A randomized controlled trial.Indian J Gastroenterol. 2024 Oct;43(5):986-994. doi: 10.1007/s12664-023-01459-0. Epub 2023 Oct 18. Indian J Gastroenterol. 2024. PMID: 37848768 Clinical Trial.
References
-
- Bray F, Ferlay J, Soerjomataram I et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018;68:394–424. - PubMed
-
- Pimentel-Nunes P, Libânio D, Marcos-Pinto R et al.Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51:365–388. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical